Tech Company Financing Transactions
EntreMed Funding Round
On 2/3/2006, EntreMed raised $30 million in funding from .
Transaction Overview
Company Name
Announced On
2/3/2006
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Undisclosed
Investors
No investors have been recorded for this company.
Proceeds Purpose
EntreMed intends to use the proceeds from the offering primarily for further clinical development of the Company's lead oncology drug candidates, Panzem NCD (2- methoxyestradiol or 2ME2), MKC-1 and ENMD-1198, as well as further development of its preclinical pipeline candidates, including Panzem for the treatment of rheumatoid arthritis.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
9620 Medical Center Drive 300
Rockville, MD 20850
USA
Rockville, MD 20850
USA
Phone
Website
Email Address
Overview
EntreMed, Inc. is a clinical-stage pharmaceutical company focused on developing next generation multi-mechanism oncology and antiinflammatory drugs that target disease cells directly and the blood vessels that nourish them.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ken Ren
VP - Finance
Sara Capitelli
VP - General Counsel
Cynthia Hu
Browse more venture capital transactions:
Prev: 2/2/2006: Certive venture capital transaction
Next: 2/3/2006: Decision Biomarkers venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to document all VC transactions involving tech companies. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs